Cheung Siu Tim
Associate Professor
Surgery
Li Ka Shing Institute of Health Sciences
Hong Kong
Biography
ST Cheung focuses on the investigation of molecular basis of human cancer, aim to improve treatment strategies and ultimately patient survival. The team has deciphered liver cancer expression profiles and metastasis associated genes. Continuation research included identification of potential therapeutic target, the novel growth factor granulin-epithelin precursor (GEP), and consolidated the roles on cancer growth, invasion, drug resistance, cancer stem cell properties, immunotherapy and antibody targeted therapy. ST Cheung focuses on the investigation of molecular basis of human cancer, aim to improve treatment strategies and ultimately patient survival. The team has deciphered liver cancer expression profiles and metastasis associated genes. Continuation research included identification of potential therapeutic target, the novel growth factor granulin-epithelin precursor (GEP), and consolidated the roles on cancer growth, invasion, drug resistance, cancer stem cell properties, immunotherapy and antibody targeted therapy.
Research Interest
Novel Targeted Therapeutics; Drug Resistance; Cancer Immunotherapy
Publications
-
Cheung PF, Cheung TT, Yip CW, Ng LW, Fung SW, Lo CM, Fan ST, Cheung ST (correspondence). Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma. Oncotarget 2016; 7: 21644-57.
